Axitinib in advanced renal cell carcinoma: real-life data and dose modification audit

Axitinib in advanced renal cell carcinoma: real-life data and dose modification audit

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical medicine (London, England) England), 2019-03, Vol.19 (2), p.s54-s54
Hauptverfasser: Parkar, Rosemeen, Boleti, Ekaterini
Format: Artikel
Sprache:eng
Schlagworte:
Clinical
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page s54
container_issue 2
container_start_page s54
container_title Clinical medicine (London, England)
container_volume 19
creator Parkar, Rosemeen
Boleti, Ekaterini
description
doi_str_mv 10.7861/clinmedicine.19-2-s54
format Article
fullrecord <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6752572</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1470211824049753</els_id><sourcerecordid>S1470211824049753</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2744-1186bded2a56473cc5e7f5dbacff955054025dc10929c0f7cd1a9189f6a604963</originalsourceid><addsrcrecordid>eNqFkMtKAzEUhoMoWKuPIMwLTE3SyczEhVKKNxDc2HU4k4semUlKMi369qZWRFduckLC__Gfj5BzRmdNW7ML3aMfrEGN3s6YLHmZRHVAJqxq5mXVyvnh152WnLH2mJyk9EYpE5WsJ2S1eMcRPXYF-gLMFry2pojWQ19o2-cDYuaGAS7zK_Rlj84WBkYowJvChGSLIRh0qGHEkBkbg-MpOXLQJ3v2PadkdXvzvLwvH5_uHpaLx1LzpqrKXKfujDUcRJ27ai1s44TpQDsnhaCiolwYzajkUlPXaMNAsla6Gmqa68-n5GrPXW-6bEBbP0bo1TriAPFDBUD198fjq3oJW1U3gouGZ4DYA3QMKUXrfrKMqp1c9VuuYlJxleXm3PU-Z_N2W7RRJY125w6j1aMyAf8hfAI8lIqf</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Axitinib in advanced renal cell carcinoma: real-life data and dose modification audit</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Parkar, Rosemeen ; Boleti, Ekaterini</creator><creatorcontrib>Parkar, Rosemeen ; Boleti, Ekaterini</creatorcontrib><identifier>ISSN: 1470-2118</identifier><identifier>EISSN: 1473-4893</identifier><identifier>DOI: 10.7861/clinmedicine.19-2-s54</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><subject>Clinical</subject><ispartof>Clinical medicine (London, England), 2019-03, Vol.19 (2), p.s54-s54</ispartof><rights>2019 © 2019 THE AUTHORS. Published by Elsevier Limited on behalf of the Royal College of Physicians.</rights><rights>Royal College of Physicians 2019. All rights reserved. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752572/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752572/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Parkar, Rosemeen</creatorcontrib><creatorcontrib>Boleti, Ekaterini</creatorcontrib><title>Axitinib in advanced renal cell carcinoma: real-life data and dose modification audit</title><title>Clinical medicine (London, England)</title><subject>Clinical</subject><issn>1470-2118</issn><issn>1473-4893</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFkMtKAzEUhoMoWKuPIMwLTE3SyczEhVKKNxDc2HU4k4semUlKMi369qZWRFduckLC__Gfj5BzRmdNW7ML3aMfrEGN3s6YLHmZRHVAJqxq5mXVyvnh152WnLH2mJyk9EYpE5WsJ2S1eMcRPXYF-gLMFry2pojWQ19o2-cDYuaGAS7zK_Rlj84WBkYowJvChGSLIRh0qGHEkBkbg-MpOXLQJ3v2PadkdXvzvLwvH5_uHpaLx1LzpqrKXKfujDUcRJ27ai1s44TpQDsnhaCiolwYzajkUlPXaMNAsla6Gmqa68-n5GrPXW-6bEBbP0bo1TriAPFDBUD198fjq3oJW1U3gouGZ4DYA3QMKUXrfrKMqp1c9VuuYlJxleXm3PU-Z_N2W7RRJY125w6j1aMyAf8hfAI8lIqf</recordid><startdate>201903</startdate><enddate>201903</enddate><creator>Parkar, Rosemeen</creator><creator>Boleti, Ekaterini</creator><general>Elsevier Ltd</general><general>Royal College of Physicians</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>201903</creationdate><title>Axitinib in advanced renal cell carcinoma: real-life data and dose modification audit</title><author>Parkar, Rosemeen ; Boleti, Ekaterini</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2744-1186bded2a56473cc5e7f5dbacff955054025dc10929c0f7cd1a9189f6a604963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Clinical</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Parkar, Rosemeen</creatorcontrib><creatorcontrib>Boleti, Ekaterini</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical medicine (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Parkar, Rosemeen</au><au>Boleti, Ekaterini</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Axitinib in advanced renal cell carcinoma: real-life data and dose modification audit</atitle><jtitle>Clinical medicine (London, England)</jtitle><date>2019-03</date><risdate>2019</risdate><volume>19</volume><issue>2</issue><spage>s54</spage><epage>s54</epage><pages>s54-s54</pages><issn>1470-2118</issn><eissn>1473-4893</eissn><pub>Elsevier Ltd</pub><doi>10.7861/clinmedicine.19-2-s54</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1470-2118
ispartof Clinical medicine (London, England), 2019-03, Vol.19 (2), p.s54-s54
issn 1470-2118
1473-4893
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6752572
source EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Clinical
title Axitinib in advanced renal cell carcinoma: real-life data and dose modification audit
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T18%3A22%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Axitinib%20in%20advanced%20renal%20cell%20carcinoma:%20real-life%20data%20and%20dose%20modification%20audit&rft.jtitle=Clinical%20medicine%20(London,%20England)&rft.au=Parkar,%20Rosemeen&rft.date=2019-03&rft.volume=19&rft.issue=2&rft.spage=s54&rft.epage=s54&rft.pages=s54-s54&rft.issn=1470-2118&rft.eissn=1473-4893&rft_id=info:doi/10.7861/clinmedicine.19-2-s54&rft_dat=%3Celsevier_pubme%3ES1470211824049753%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S1470211824049753&rfr_iscdi=true